Shohei Eto
Hiroshima University(JP)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19, Diabetes and associated disorders, DNA Repair Mechanisms
Most-Cited Works
- → Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths(2021)617 cited
- → The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies(2022)183 cited
- → Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19(2022)47 cited
- → The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies(2022)24 cited
- → Cyclic intravenous pamidronate in a very low‐birthweight infant with osteogenesis imperfecta(2018)5 cited
- → MSH2 deletion with CREBBP and KRAS mutations in pediatric high‐hyperdiploid acute lymphoblastic leukemia(2017)1 cited
- Autoantibodies neutralizing type I IFNs are present in similar to 4% of uninfected individuals over 70 years old and account for similar to 20% of COVID-19 deaths(2021)